https://canceradvocacy.org/wp-content/uploads/2016/11/HeatherVSJ.jpg
2048
1462
actualizedevs
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Horiz_TwoColor.svg
actualizedevs2016-11-01 16:24:232016-11-01 16:24:23Guest Post: Mesothelioma Awareness and the Danger of Asbestos ExposureNCCS is now Cancer Nation. Find out more about our next chapter. Join Us
News
https://canceradvocacy.org/wp-content/uploads/2016/11/HeatherVSJ.jpg
2048
1462
actualizedevs
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Horiz_TwoColor.svg
actualizedevs2016-11-01 16:24:232016-11-01 16:24:23Guest Post: Mesothelioma Awareness and the Danger of Asbestos Exposure
NCCS Marks 30 Years of Cancer Survivorship Advocacy
On October 13, 2016, the National Coalition for Cancer Survivorship (NCCS) recognized its 30th anniversary of advocating to improve…

NCCS’ Paper on Oncologist-Patient Communication Published in Evidence-Based Oncology Journal
Earlier this year, the National Coalition for Cancer Survivorship (NCCS) conducted focus groups with patients and oncologists to gain…

NCCS Presents the Inaugural Ellen Stovall Award to Douglas W. Blayney, MD, FACP (Video)
At the National Coalition for Cancer Survivorship’s (NCCS) 30th Anniversary Reception on October 13, 2016, NCCS presented the inaugural…

Cancer Moonshot Blue Ribbon Panel Recommends Research to Minimize Debilitating Side Effects of Cancer Treatment
Today, the Cancer Moonshot Blue Ribbon Panel released ten recommendations to accelerate progress in cancer research. One recommendation…

NCCS Comments on CMS’s Proposed Revisions to the 2017 Physician Fee Schedule
NCCS submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed revisions to the 2017 Physician Fee…

NCCS Comments on the FDA’s PDUFA Proposed Commitment Letter
NCCS submitted comments to the Food and Drug Administration (FDA) on the letter representing the agreement between FDA and regulated industry on goals for the re-authorization of the Prescription Drug User Fee Act (PDUFA VI). NCCS participated in the PDUFA stakeholder meetings held over the last year, and we support the role [...]

Highlights from the 2016 CPAT Symposium and Hill Day
In June, over 50 patient advocates gathered in Washington, D.C. to take part in the NCCS 2016 Cancer Policy & Advocacy Team (CPAT)…

